 |
|
Non-alcoholic fatty liver disease: the pathologist’s perspective
Wei-Qiang Leow, Anthony Wing-Hung Chan, Paulo Giovanni L. Mendoza, Regina Lo, Kihan Yap, Haeryoung Kim
Clin Mol Hepatol. 2023;29(Suppl):S302-S318. Published online 2022 Nov 15 DOI: https://doi.org/10.3350/cmh.2022.0329
|
|
Citations to this article as recorded by
 Liver Cancer Risk Across Metabolic Dysfunction-Associated Steatotic Liver Disease and/or Alcohol: A Nationwide Study
Byungyoon Yun, Heejoo Park, Sang Hoon Ahn, Juyeon Oh, Beom Kyung Kim, Jin-Ha Yoon
American Journal of Gastroenterology.2025; 120(2): 410. CrossRef Female C57BL/6 mice exhibit protection against nonalcoholic fatty liver disease and diabesity accompanied by differential regulation of hepatic lipocalin prostaglandin D2 synthase
Md Asrarul Islam, Rhema Khairnar, Joshua Fleishman, Sandra E. Reznik, Louis Ragolia, Shruthi Gobbooru, Sunil Kumar
Molecular and Cellular Endocrinology.2025; 595: 112404. CrossRef Extracellular vesicle-mediated approaches for the diagnosis and therapy of MASLD: current advances and future prospective
Swasthika Gurjar, Ramanarayana Bhat A, Raghavendra Upadhya, Revathi P. Shenoy
Lipids in Health and Disease.2025;[Epub] CrossRef Do Child–Turcotte–Pugh and nutritional assessments predict survival in cirrhosis: A longitudinal study
Randhall B Carteri, Claudio A Marroni, Luis F Ferreira, Letícia P Pinto, Juliana Czermainski, Cristiane V Tovo, Sabrina A Fernandes
World Journal of Hepatology.2025;[Epub] CrossRef Association of Stroke With Metabolic Dysfunction–Associated Fatty Liver Disease With and Without CKD
Yuhao Li, Shouling Wu, Jingli Gao, Yijun Zhang, Yingting Zuo, Xue Tian, Shuohua Chen, Aijun Xing, Anxin Wang, Yan He
American Journal of Kidney Diseases.2024; 83(4): 477. CrossRef Sex-specific differences in ectopic fat and metabolic characteristics of paediatric nonalcoholic fatty liver disease
Eun Hye Lee, Ji Young Kim, Hye Ran Yang
International Journal of Obesity.2024; 48(4): 486. CrossRef Research progress, challenges and perspectives of phospholipids metabolism in the LXR‑LPCAT3 signaling pathway and its relation to NAFLD (Review)
Junmin Wang, Jiacheng Li, Yugang Fu, Yingying Zhu, Liubing Lin, Yong Li
International Journal of Molecular Medicine.2024;[Epub] CrossRef Proposal of a Novel Serological Algorithm Combining FIB-4 and Serum M2BPGi for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease
Sang Yi Moon, Yang Hyun Baek, Se Young Jang, Dae Won Jun, Ki Tae Yoon, Young Youn Cho, Hoon Gil Jo, Ae Jeong Jo
Gut and Liver.2024; 18(2): 283. CrossRef Lipid droplet detection in histopathological images using reinforcement learning
Yoshitomi Harada, Haruto Nishida, Keiko Matsuura
Biotechnology & Biotechnological Equipment.2024;[Epub] CrossRef Evaluating the relative importance of different blood pressure indices in screening for NAFLD: a survey report based on a health examination population
Chong Hu, Ziqi Yu, Changli Wei, Guotai Sheng, Jianyong Chen, Yang Zou
Frontiers in Cardiovascular Medicine.2024;[Epub] CrossRef Perilipins: A family of five fat‐droplet storing proteins that play a significant role in fat homeostasis
Preethi Chandrasekaran, Sabine Weiskirchen, Ralf Weiskirchen
Journal of Cellular Biochemistry.2024;[Epub] CrossRef A preclinical model of severe NASH-like liver injury by chronic administration of a high-fat and high-sucrose diet in mice
Rose A. Willett, Volodymyr P. Tryndyak, Jennifer M. Hughes Hanks, Lana Elkins, Suresh K. Nagumalli, Mark I. Avigan, Sharon A. Ross, Gonçalo Gamboa da Costa, Frederick A. Beland, Ivan Rusyn, Igor P. Pogribny
Toxicology and Applied Pharmacology.2024; 491: 117046. CrossRef A peptide alleviated oxidative damages in the L02 cells and mice liver
Gan Gao, Zhiyang Zhang, Qiheng Wang, Zhihui Xie, Bing Liu, Hongliang Huang
Biochemical and Biophysical Research Communications.2024; 734: 150643. CrossRef Targeting long non-coding RNA H19 as a therapeutic strategy for liver disease
Yulan Shi, Fenghua Qu, Shiyun Zeng, Xinchen Wang, Yuting Liu, Qirui Zhang, Ding Yuan, Chengfu Yuan
Progress in Biophysics and Molecular Biology.2024; 194: 1. CrossRef Transcription factor ETV4 plays a critical role in the development of non-alcoholic fatty liver disease
Bhavani Gadiraju, Jhansi Magisetty, Vijay Kondreddy
International Journal of Biological Macromolecules.2024; 282: 137235. CrossRef Arctium lappa L. Extract Alleviates Non-Alcoholic Fatty Liver Injury in Mices
娜 李
Hans Journal of Medicinal Chemistry.2024; 12(04): 309. CrossRef Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: A Review and Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
Jaehyun Bae, Eugene Han, Hye Won Lee, Cheol-Young Park, Choon Hee Chung, Dae Ho Lee, Eun-Hee Cho, Eun-Jung Rhee, Ji Hee Yu, Ji Hyun Park, Ji-Cheol Bae, Jung Hwan Park, Kyung Mook Choi, Kyung-Soo Kim, Mi Hae Seo, Minyoung Lee, Nan-Hee Kim, So Hun Kim, Won-
Diabetes & Metabolism Journal.2024; 48(6): 1015. CrossRef Evaluation of autoimmune phenomena in patients with nonalcoholic fatty liver disease on the basis of liver pathology
Yu-Jin Zhu, Yan Zhang, Yao Rao, Yong Jiang, Yong-Gang Liu, Jian-Zhou Li, Jia-Qi Yuan, Ying Zhao, Wen-Wen Zheng, Lin Ma, Chun-Yan Wang, Jia Li
World Journal of Hepatology.2024; 16(12): 1407. CrossRef Gut microbiome and nonalcoholic fatty liver disease
Meng-Yuan Wu, Jian-Gao Fan
Hepatobiliary & Pancreatic Diseases International.2023; 22(5): 444. CrossRef
|